Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Wednesday, October 21, 2026

Back to today

From X

@ChrisCamillo 3 clicks

Chris Camillo on X

One of the most important disciplines in investing is constantly updating the best argument against your own position. Not dismissing it. Not looking for reasons it’s wrong. Actually understanding it well enough to decide how much conviction your own thesis deserves. $AMZN has badly lagged the market and many other AI names recently, and I think the counter thesis has evolved. The biggest new threat is agentic commerce. Meta’s Muse and other AI agents could increasingly control product discovery and purchasing, potentially weakening Amazon’s retail and advertising moat. That’s real. But I think it plays out slowly, Amazon will adapt through its own agents, including Project Moonraker, or partnerships that are seeking access into and monetization from the world’s largest ecommerce platform, and in an agent-first world the upside to AWS, Trainium, Graviton and Amazon’s broader AI infrastructure business could ultimately more than offset the advertising dollars at risk. Then there’s Anthropic. A recent barrage of negative headlines around slowing growth and Meta/Microsoft reducing Claude usage has spilled over into $AMZN sentiment. Again, worth taking seriously. But much of that narrative looks incomplete. Anthropic’s revenue growth remains extraordinary, its IPO appears very much alive, and its massive long term commitment to AWS remains intact. We are still early and one can make a strong argument that AWS has more to gain from an open source first AI world than it would lose from Anthropic’s and OAI’s relative weakness, if it even plays out that way. And now sharply higher diesel prices create another near term headwind to Amazon’s shipping margins. That’s real too. But either fuel prices normalize or as with past cost inflation Amazon eventually passes much of the higher cost through while continuing to drive down fulfillment costs. I don’t need the counter thesis to be wrong to own $AMZN. I just need the bull thesis to be more right.

Investor Letters

All letters

Eli Lilly And Co. (LLY)

Eli Lilly's Mounjaro and Zepbound drove 2025 revenue to $65.2 billion as the drugmaker expands AI partnerships with Nvidia, Isomorphic…

LLY $1.2T
SixSigmaCapital: Navigating the Financial Markets 25 clicks

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $2B
The Oak Bloke 27 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $9.7B
CV's Substack 28 clicks
DOMO · long

Domo INC

Domo is valued as an NOL shell, with the long case tied to the timing and value of its NOL realization.

DOMO
Value Investors Club 11 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M
Calvin Blissett 10 clicks

Heico Corporation

HEICO sells FAA-approved aircraft replacement parts at 30% to 50% discounts to OEMs, gaining customers as restrictive aftermarket contracts…

HEI $42B
D Invests 13 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 247

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.